Morgane completed her PhD in 2018 at the Institut Curie in Paris (France), where she worked on identifying novel treatments for group 3 Medulloblastoma patients. She was a Postdoctoral Research Fellow at the Hospital for Sick Children in Toronto (Canada) from 2019 to 2022, where she worked on understanding the role of the gut microbiota during brain tumours initiation and progression. The microbiota being the name given to all the bacteria living in our guts.